Lung Cancer Canada

Ottawa, Ontario K1H 8L6, CanadaNot linked to an institution yet

The trials here

What the trial at this site is about, from its registry record.

Active, not recruiting
Phase III Study of AK112 for NSCLC Patients
NCT06396065· Phase 3· Summit Therapeutics· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Under construction, not live – Lung Cancer Canada: trial site – Frontlight Research